Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Office of Inspector General Drops Challenge To Forest CEO Solomon

This article was originally published in The Pink Sheet Daily

Executive Summary

Amid drama from dissident investor Carl Icahn, Forest is relieved of the fear that the federal OIG could bar its CEO from contracting with government health care programs.

You may also be interested in...



Solomon To Step Aside As Forest Exec; Icahn Wins Another Victory

President and CEO of Forest Laboratories Howard Solomon will retire at the end of the year. Activist investor Carl Icahn has long inveighed against the 85 year-old exec. This could signal a renewed effort to get Forest back on track, now that its Lexapro losses have slashed revenue and a Namenda expiry looms.

Forest Holds Off Icahn, But Battle Likely Looms

Forest shareholders elect the company's slate of board members at its annual meeting, shooting down activist investor Carl Icahn's picks.

Forest Holds Off Icahn, But Battle Likely Looms

Forest shareholders elect the company's slate of board members at its annual meeting, shooting down activist investor Carl Icahn's picks.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel